{{Rsnum
|rsid=10074959
|Chromosome=5
|position=104872312
|Orientation=plus
|GMAF=0.3049
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.1 | 35.4 | 57.5
| HCB | 11.0 | 32.4 | 56.6
| JPT | 3.5 | 48.7 | 47.8
| YRI | 23.1 | 51.7 | 25.2
| ASW | 19.3 | 47.4 | 33.3
| CHB | 11.0 | 32.4 | 56.6
| CHD | 6.4 | 43.1 | 50.5
| GIH | 0.0 | 18.0 | 82.0
| LWK | 18.5 | 54.6 | 26.9
| MEX | 6.9 | 36.2 | 56.9
| MKK | 11.5 | 48.1 | 40.4
| TSI | 7.8 | 42.2 | 50.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=1E-6
  |OR=1.52
  |ORtxt=[1.048-2.217]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}